InnoMedica Schweiz AG
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease (NCT06431971) | InnoMedica Schweiz AG | 2024-08-01 |
| Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients (NCT04976127) | InnoMedica Schweiz AG | 2021-12-11 |
Track InnoMedica Schweiz AG automatically
Every clearance here is in the API, with alerts when new ones post.